BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,445 | -1.3% | 2,515,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,476 | -26.0% | 2,515,000 | -22.7% | 0.00% | -25.0% |
| Q1 2023 | $3,344 | +3277.8% | 3,252,000 | +3359.6% | 0.00% | – |
| Q4 2022 | $99 | -100.0% | 94,000 | -99.7% | 0.00% | -100.0% |
| Q1 2021 | $36,314,000 | +9.6% | 35,799,000 | +16.2% | 0.04% | +4.8% |
| Q4 2020 | $33,127,000 | -32.7% | 30,799,000 | -34.2% | 0.04% | -39.1% |
| Q3 2020 | $49,225,000 | +30.5% | 46,799,000 | +51.9% | 0.07% | +19.0% |
| Q2 2020 | $37,715,000 | +17.8% | 30,799,000 | +1.0% | 0.06% | -1.7% |
| Q1 2020 | $32,022,000 | -13.2% | 30,485,000 | -12.5% | 0.06% | +11.3% |
| Q4 2019 | $36,879,000 | +7.5% | 34,825,000 | 0.0% | 0.05% | -5.4% |
| Q3 2019 | $34,319,000 | -5.3% | 34,825,000 | 0.0% | 0.06% | -5.1% |
| Q2 2019 | $36,239,000 | +6.4% | 34,825,000 | +4.9% | 0.06% | +5.4% |
| Q1 2019 | $34,050,000 | +2.9% | 33,200,000 | 0.0% | 0.06% | -8.2% |
| Q4 2018 | $33,097,000 | +75.0% | 33,200,000 | +87.6% | 0.06% | +96.8% |
| Q3 2018 | $18,908,000 | +278.7% | 17,700,000 | +254.0% | 0.03% | +244.4% |
| Q4 2017 | $4,993,000 | -63.6% | 5,000,000 | -63.0% | 0.01% | -64.0% |
| Q3 2017 | $13,710,000 | – | 13,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 19,413,000 | $19,245,611 | 1.50% |
| SSI INVESTMENT MANAGEMENT LLC | 9,386,000 | $9,219,566 | 0.65% |
| PFM Health Sciences, LP | 15,000,000 | $14,771,520 | 0.57% |
| RWC Asset Management LLP | 11,000,000 | $10,848,475 | 0.52% |
| Sonora Investment Management Group, LLC | 6,280,000 | $6,184,858 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,020,000 | $23,654,128 | 0.46% |
| Lombard Odier Asset Management (Europe) Ltd | 7,224,000 | $7,124,489 | 0.34% |
| MACKAY SHIELDS LLC | 10,123,000 | $9,943,520 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,478,000 | $9,323,983 | 0.25% |
| Nicholas Investment Partners, LP | 2,940,000 | $2,887,868 | 0.20% |